TXG Stock Analysis: Buy, Sell, or Hold?
TXG - 10x Genomics, Inc. Class A Common Stock
$20.20
-0.60 (-2.88%)
▼
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 11, 2026
10d
Get Alerted When TXG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called TXG this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: TXG shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: TXG shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: TXG is currently trading at $20.20, which is considered fair relative to its 30-day fair value range of $17.32 to $21.85.
Technical Outlook: Technically, TXG is in a strong uptrend. Immediate support is located at $19.34, while resistance sits at $23.56.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $18.08. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TXG is in a strong uptrend. Immediate support is located at $19.34, while resistance sits at $23.56.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $18.08. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$17.32 -
$21.85
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
64.2%
Protect Your Profits
Holding TXG? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 13.1% above Wall St target ($18.08)
- CAUTION: Recommendation downgraded due to -9.7% 5-day decline
Fair Price Analysis
30-Day Fair Range
$17.32 -
$21.85
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$19.34
Resistance Level
$23.56
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-53.79
Wall Street Target
$18.08
(-13.1%)
Revenue Growth (YoY)
-1.7%
Profit Margin
-11.9%
Last updated: January 31, 2026 4:13 AM ET
Data refreshes hourly during market hours. Next update: 5:13 AM
Data refreshes hourly during market hours. Next update: 5:13 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TXG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Adam Taich
SELL
22315 shares
2025-08-22
Benjamin J Hindson
SELL
7486 shares
2025-08-22
Serge Saxonov
SELL
9348 shares
2025-08-22
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$310 | 54 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 57 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 60 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$29 | 48 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 55 HOLD |
Advanced TXG Option Strategies
Professional options setups generated by AI based on today's TXG price and gamma walls.
